A recent research has found treatment for multiple sclerosis (MS). During the research, nanoparticles taken from synthetic molecule known as PLG were induced in mice affected with MS. The nanoparticles helped in reducing the inflammation caused by MS.

PLG is naturally found in a human body in the form of lactic and glycolic acids. During the study, it was found that the nanoparticles reduced the inflammation caused by MS. Researchers are hopeful that the new vaccine would bring revolution in the treatment of MS.

Corresponding author of the research Stephen Miller said, "This is a highly significant breakthrough in translational immunotherapy. The holy grail is to develop a therapy that is specific to the pathological immune response, in this case the body attacking myelin".

Further researches are required to be conducted to make sure that the vaccine doesn't cause any side effects. Researchers are hopeful that the vaccine thus found could also be used for treating patients affected with asthma and cancer. The nanoparticles boost immune system enabling body to fight infectious cells. The findings of researchers have been published in the journal Nature Biotechnology. It is hoped that the vaccine would become available for clinical use soon.